InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.41%
)
US TECH 100
19,528.00
(
0.90%
)
Dow Jones
42,052.19
(
0.69%
)
Brent Oil
72.91
(
0.00%
)
Bitcoin
67,632.35
(
-2.42%
)
Post# of 253511
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120661
Boards Moderated 13
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Mufaso post# 252382

Wednesday, 06/26/2024 5:31:33 PM

Wednesday, June 26, 2024 5:31:33 PM

Post# of 253511
Re: ACIP's RSV recommendations

It appears to set narrower limits on which adults aged 60 to 74 should receive the shots.

I'm not sure Barron's is right about this. My interpretation is that the "shared decision" scenario remains in effect for adults age 50-64 who do not have a major heath issue; if my interpretation is correct, then ACIP did not narrow vaccination eligibility for age 50-64, but rather strengthened the recommendation for a subset of this age group (those who fall in the third bullet point of #msg-174663288).

I did not listen to the ACIP hearing, so my interpretation might be wrong.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up